Allscripts Adds M*Modal’s Speech Understanding(TM) to EHR Platforms and Mobility Solutions
M*Modal Technology Powers Allscripts EHRs for Capture of Comprehensive Patient Story
FRANKLIN, Tenn. (January 27, 2012) – MModal Inc.(NASDAQ/GS: MODL), a leading provider of clinical narrative capture services, Speech Understanding(TM) technology and clinical documentation workflow, today announced that it has entered into a strategic reseller and development relationship with Allscripts (NASDAQ: MDRX) for its speech and language understanding technology, which will be available in key solutions for Allscripts clients across all ambulatory and acute-care platforms. The relationship will provide capabilities to create content-rich, voice-driven narrative patient documentation within Allscripts electronic health record (EHR) systems.
M*Modal’s technology, based on its Speech Understanding(TM) and Natural Language Understanding (NLU) platform, will empower Allscripts market-leading EHRs, providing Allscripts clients with innovative new technology focused on making electronic health records easier to learn and use. The integration supports Allscripts commitment to offer flexible note-creation options.
In addition, Allscripts is incorporating the M*Modal technology into its mobility offerings including its Sunrise Mobile(TM) MD II product for on-the-go speech understanding capability. Using Sunrise Mobile for the iPad®, physicians can view complete patient context, use real-time speech to create immediate and detailed progress reports and other clinical notes, and have this documentation available to drive actions in the Allscripts Sunrise Clinical Manager(TM) system.
“We are firmly committed to open software that delivers intuitive user experience and captures complete, accurate, and high-quality patient information,” said Glen Tullman, Chief Executive Officer of Allscripts. “M*Modal’s technology optimizes the physician’s ability to generate a detailed story very efficiently in our Enterprise EHR platform from either the workstation or a mobile device.”
M*Modal’s technology takes advantage of its cloud-based enterprise documentation platform to enable healthcare providers to speech-enable existing health information systems including EHRs, radiology information systems (RIS) and picture archiving and communication systems (PACS). Providers can use their voice, in addition to keyboard and mouse, to seamlessly interact with their desktop clinical applications, including the dictation of medical narrative and voice navigation within 3rd-party applications. Using this solution, providers can improve documentation efficiency and avoid difficulties associated with template-based point-and-click systems, augmenting discretely captured data with a narrative of the patient’s story. This ultimately improves the quality of clinical documentation.
“Allscripts is a leader in EHR technology and a demonstrated innovator in the healthcare industry,” said Vern Davenport, Chairman and CEO of M*Modal. “We are pleased to collaborate with Allscripts to bring its large enterprise physician user-base our innovative technology to generate meaningful, actionable clinical content in ways that respect how they want to document patient encounters. With more than 165,000 physicians using M*Modal technology and services, we are poised to provide even greater value to ambulatory providers and, ultimately, patients.”
M*Modal (NASDAQ/GS: MODL)is a leading provider of clinical narrative capture services, Speech Understanding(TM) technology and clinical documentation workflow. M*Modal’s enterprise solutions
Information provided and statements contained in this press release that are not purely historical, such as statements regarding our expectations regarding our future business plans are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, specific factors discussed herein and in other releases and public filings made by the Company (including filings by the Company with the Securities and Exchange Commission). Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.